Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Functionally Altered GPI-Anchor Negative Treg Following Alemtuzumab-Based T-Cell Depletion Are Associated with Acute Gvhd.

Eva M Wagner, Lukas A Schaefer, Tobias Bopp, Matthias Theobald, MD, PhD, Wolfgang Herr, MD, Ralf G Meyer

Blood (2012) 120 (21): 3059.

https://doi.org/10.1182/blood.V120.21.3059.3059

Published: 2012

Journal Articles

Impact of Prophylactic CD8-Depleted Donor-Lymphocyte Infusions After Allogeneic Hematopoietic Stem Cell Transplantation and Alemtuzumab Mediated T-Cell Depletion,

Eva M Wagner, MD, Daniela Wehler, MD, Karin Kolbe, MD, Matthias Theobald, MD, PhD, Wolfgang Herr, MD, Ralf G Meyer, MD

Blood (2011) 118 (21): 4109.

https://doi.org/10.1182/blood.V118.21.4109.4109

Published: 2011

Journal Articles

Long-Term Persistence of Functionally Altered GPI-Anchor Negative T-Cell Subsets After Alemtuzumab-Based T-Cell Depleted Hematopoietic Stem Cell Transplantation.

Eva M Wagner, Aline N Lay, Timo Schmitt, Julia Hemmerling, Diana Wolff, Christoph Huber, Wolfgang Herr, Ralf G Meyer

Blood (2009) 114 (22): 2438.

https://doi.org/10.1182/blood.V114.22.2438.2438

Published: 2009

Journal Articles

The CD38-Positive and CD38-Negative Subsets of CD34(high)-Positive Primary Acute Myeloid Leukemia Blasts Differ Considerably in the Expression of Immune Recognition Molecules

Eva Distler, Anna Jürchott, Abdo Konur, Astrid Schneider, Eva M. Wagner, Christoph Huber, Ralf G. Meyer, Wolfgang Herr

Blood (2008) 112 (11): 2936.

https://doi.org/10.1182/blood.V112.11.2936.2936

Published: 2008

Journal Articles

Reconstitution of CD52-Negative CD4 T Cells after Alemtuzumab-Based T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation

Eva M Wagner, MD, Aline N Lay, Sina Wenzel, Timo Schmitt, Julia Hemmerling, Abdo Konur, PhD, Klaus Bender, PhD, Christoph Huber, MD, Wolfgang Herr, MD, Ralf G Meyer, MD

Blood (2008) 112 (11): 1182.

https://doi.org/10.1182/blood.V112.11.1182.1182

Published: 2008

Journal Articles

CD8-Depleted Donor Lymphocyte Infusions Convert Mixed into Complete Donor T-Cell Chimerism after T-Cell Depleted Allogeneic Stem Cell Transplantation.

Ralf G Meyer, MD, Eva M Wagner, MD, Timo Schmitt, Klaus Bender, PhD, Udo F Hartwig, PhD, Christoph Huber, MD, Karin Kolbe, MD, Wolfgang Herr, MD

Blood (2008) 112 (11): 2160.

https://doi.org/10.1182/blood.V112.11.2160.2160

Published: 2008

Journal Articles

Vaccination with WT1 and PR3 Derived Peptides in Patients with AML/MDS and MUC1 Peptides in Patients with Multiple Myeloma - Preliminary Results.

Eva M. Wagner, Juergen Kuball, MD, Mohamed Wattad, MD, Christoph Huber, MD, Wolfgang Heit, MD, Matthias Theobald, MD

Blood (2006) 108 (11): 4582.

https://doi.org/10.1182/blood.V108.11.4582.4582

Published: 2006

NARROW

Functionally Altered GPI-Anchor Negative Treg Following Alemtuzumab-Based T-Cell Depletion Are Associated with Acute Gvhd.

Impact of Prophylactic CD8-Depleted Donor-Lymphocyte Infusions After Allogeneic Hematopoietic Stem Cell Transplantation and Alemtuzumab Mediated T-Cell Depletion,

Long-Term Persistence of Functionally Altered GPI-Anchor Negative T-Cell Subsets After Alemtuzumab-Based T-Cell Depleted Hematopoietic Stem Cell Transplantation.

The CD38-Positive and CD38-Negative Subsets of CD34(high)-Positive Primary Acute Myeloid Leukemia Blasts Differ Considerably in the Expression of Immune Recognition Molecules

Reconstitution of CD52-Negative CD4 T Cells after Alemtuzumab-Based T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation

CD8-Depleted Donor Lymphocyte Infusions Convert Mixed into Complete Donor T-Cell Chimerism after T-Cell Depleted Allogeneic Stem Cell Transplantation.

Vaccination with WT1 and PR3 Derived Peptides in Patients with AML/MDS and MUC1 Peptides in Patients with Multiple Myeloma - Preliminary Results.

Email alerts

ASH Publications

American Society of Hematology

Functionally Altered GPI-Anchor Negative Treg Following Alemtuzumab-Based T-Cell Depletion Are Associated with Acute Gvhd.

Impact of Prophylactic CD8-Depleted Donor-Lymphocyte Infusions After Allogeneic Hematopoietic Stem Cell Transplantation and Alemtuzumab Mediated T-Cell Depletion,

Long-Term Persistence of Functionally Altered GPI-Anchor Negative T-Cell Subsets After Alemtuzumab-Based T-Cell Depleted Hematopoietic Stem Cell Transplantation.

The CD38-Positive and CD38-Negative Subsets of CD34(high)-Positive Primary Acute Myeloid Leukemia Blasts Differ Considerably in the Expression of Immune Recognition Molecules

Reconstitution of CD52-Negative CD4 T Cells after Alemtuzumab-Based T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation

CD8-Depleted Donor Lymphocyte Infusions Convert Mixed into Complete Donor T-Cell Chimerism after T-Cell Depleted Allogeneic Stem Cell Transplantation.

Vaccination with WT1 and PR3 Derived Peptides in Patients with AML/MDS and MUC1 Peptides in Patients with Multiple Myeloma - Preliminary Results.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only